HIP
ABBV icon

HUB Investment Partners’s AbbVie ABBV Stock Holding History

HUB Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40M Buy
158,806
+41,607
+36% +$8.95M 0.72% 25
2026
Q1 		$25.5M Buy
117,199
+8,515
+8% +$1.89M 0.61% 31
2025
Q4 		$24.8M Buy
108,684
+2,014
+2% +$459K 0.64% 31
2025
Q3 		$24.7M Buy
106,670
+4,238
+4% +$863K 0.82% 23
2025
Q2 		$19M Buy
102,432
+6,154
+6% +$1.14M 0.63% 34
2025
Q1 		$20.2M Buy
96,278
+27,228
+39% +$5.29M 0.8% 30
2024
Q4 		$12.3M Buy
69,050
+2,565
+4% +$472K 0.51% 51
2024
Q3 		$13.1M Buy
66,485
+2,895
+5% +$540K 0.57% 50
2024
Q2 		$10.9M Buy
63,590
+6,826
+12% +$1.13M 0.41% 55
2024
Q1 		$10.3M Sell
56,764
-1,884
-3% -$325K 0.56% 49
2023
Q4 		$9.09M Buy
58,648
+16,293
+38% +$2.38M 0.62% 42
2023
Q3 		$6.31M Buy
42,355
+4,696
+12% +$689K 0.95% 25
2023
Q2 		$5.07M Buy
37,659
+7,414
+25% +$1.09M 0.84% 31
2023
Q1 		$4.82M Buy
30,245
+11,694
+63% +$1.79M 1% 26
2022
Q4 		$3M Buy
18,551
+1,549
+9% +$238K 0.65% 33
2022
Q3 		$2.28M Buy
17,002
+1,751
+11% +$251K 0.69% 39
2022
Q2 		$2.34M Buy
15,251
+13,795
+947% +$2.11M 0.73% 37
2022
Q1 		$236K Sell
1,456
-193
-12% -$28K 0.06% 162
2021
Q4 		$223K Sell
1,649
-939
-36% -$111K 0.05% 183
2021
Q3 		$279K Sell
2,588
-1,080
-29% -$123K 0.07% 175
2021
Q2 		$413K Sell
3,668
-1,482
-29% -$167K 0.11% 132
2021
Q1 		$557K Buy
5,150
+741
+17% +$79.3K 0.16% 114
2020
Q4 		$386K Buy
+4,409
New +$424K 0.18% 105

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HUB Investment Partners's ABBV Position: Q2 2026 in Review

HUB Investment Partners increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $8.95M and bringing the position to 158,806 shares worth $40M. The position accounts for 0.72% of the portfolio, ranked #25.

HUB Investment Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HUB Investment Partners held 158,806 shares of AbbVie worth $40M as of Q2 2026.
  • HUB Investment Partners bought 41,607 AbbVie shares in Q2 2026, an estimated $8.95M.
  • AbbVie made up 0.72% of HUB Investment Partners's portfolio in Q2 2026, its #25 holding.
  • HUB Investment Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.